For example, noncoding erythropoietin (EPO) promoter variants recently linked to hereditary erythrocytosis suggest that population-enriched regulatory mutations can elevate red cell production independent of serum EPO levels detectable by standard assays (3, 4). This evidence concerns the gene EPO and polycythemia.